HC Wainwright resumed coverage on Iterum Therapeutics
$ITRM
Biotechnology: Pharmaceutical Preparations
Health Care
HC Wainwright resumed coverage of Iterum Therapeutics with a rating of Hold
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/27/2021 | Sell → Hold | Gabelli & Co. | |
| 7/26/2021 | Buy → Neutral | HC Wainwright & Co. |